XML 15 R3.htm IDEA: XBRL DOCUMENT v3.23.3
INTERIM CONSOLIDATED STATEMENTS OF PROFIT OR LOSS AND OTHER COMPREHENSIVE LOSS - USD ($)
$ in Thousands
 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
INTERIM CONSOLIDATED STATEMENTS OF PROFIT OR LOSS AND OTHER COMPREHENSIVE LOSS    
Revenue $ 9,916 $ 9,548
Cost of revenue 4,188 3,768
Gross profit 5,728 5,780
Operating expenses:    
Research and development 6,014 5,119
Selling and marketing 7,081 4,901
General and administrative 6,079 4,997
Transaction-related costs 3,703 812
Share listing expense 46,717  
Total operating expenses 69,594 15,829
Operating loss (63,866) (10,049)
Change in fair value of warrants 7,404  
Finance income 1,690 171
Finance expenses (223) (306)
Financing income (expenses), net 1,467 (135)
Loss before income taxes (54,995) (10,184)
Income taxes 3 38
Loss (54,998) (10,222)
Other comprehensive income (loss) (net of tax effect):    
Remeasurement gain from defined benefit plans   225
Total components that will not be reclassified subsequently to profit or loss   225
Total comprehensive loss $ (54,998) $ (9,997)
Basic loss per Ordinary share $ (1.33) $ (1.90)
Diluted loss per Ordinary share $ (1.33) $ (1.90)
Weighted average number of shares outstanding used to compute basic loss per share 41,802,993 7,703,799
Weighted average number of shares outstanding used to compute diluted loss per share 41,802,993 7,703,799